<DOC>
	<DOCNO>NCT01452763</DOCNO>
	<brief_summary>The purpose study evaluate efficacy TAK-438 , daily ( QD ) compare AG-1749 ( Lansoprazole ) patient history gastric duodenal ulcer require long-term therapy low-dose aspirin .</brief_summary>
	<brief_title>Efficacy Safety TAK-438 Prevention Recurrent Gastric Duodenal Ulcers During Therapy Low-dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Duodenal Ulcer</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Lansoprazole</mesh_term>
	<mesh_term>Dexlansoprazole</mesh_term>
	<criteria>1 . Participants require continuous lowdose aspirin therapy treatment period study drug 2 . Participants history ulcer stomach duodenum , endoscopically confirm 3 . Outpatient ( include inpatient examination ) 1 . Participants schedule change type dosage regimen lowdose aspirin 2 . Participants ulcer bleed stomach duodenum , endoscopically confirm 3 . Participants small intestine bleeding , large intestine bleeding , gastrointestinal bleed unknown etiology 4 . Participants history surgery affect gastric acid secretion ( e.g. , resection upper gastrointestinal tract , vagotomy ) schedule undergo surgery 5 . Participants previous current history ZollingerEllison syndrome , gastric acid hypersecretion disorder 6 . Participants previous current history aspirininduced asthma</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Drug Therapy</keyword>
</DOC>